(Q46006392)
Statements
1 reference
Tolvaptan, a selective oral vasopressin V2 receptor antagonist, ameliorates podocyte injury in puromycin aminonucleoside nephrotic rats. (English)
1 reference
Tadashi Okada
1 reference
Toshifumi Sakaguchi
1 reference
Ikuji Hatamura
1 reference
Fumie Saji
1 reference
Shigeo Negi
1 reference
Haruhisa Otani
1 reference
Yasuteru Muragaki
1 reference
Hiroshi Kawachi
1 reference
Takashi Shigematsu
1 reference
19 May 2009
1 reference
13
1 reference
5
1 reference
438-446
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference